tetradecanoylphorbol acetate has been researched along with Abnormalities, Drug-Induced in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Hales, BF | 1 |
| Busa, WB; Gimlich, RL | 1 |
| Brown, NA; Huber, BE | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
12-O-tetradecanoyl-phorbol-13-acetate-induced rat embryo malformations in vitro are associated with an increased relative abundance of embryonic E-cadherin mRNA.
Topics: Abnormalities, Drug-Induced; Analysis of Variance; Animals; Cadherins; Embryo, Mammalian; Embryonic and Fetal Development; Enzyme Activation; Protein Kinase C; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetradecanoylphorbol Acetate; Yolk Sac | 1994 |
Lithium-induced teratogenesis in frog embryos prevented by a polyphosphoinositide cycle intermediate or a diacylglycerol analog.
Topics: Abnormalities, Drug-Induced; Animals; Blastomeres; Central Nervous System; Diglycerides; Exocrine Glands; Eye; Glycerides; Inositol; Lithium; Microelectrodes; Microinjections; Mutation; Phosphatidylinositol Phosphates; Phosphatidylinositols; Tetradecanoylphorbol Acetate; Xenopus laevis | 1989 |
12-O-Tetradecanoyl-phorbol-13-acetate (TPA) induced congenital kidney defects and embryomortality in the CD-1 mouse.
Topics: Abnormalities, Drug-Induced; Animals; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Kidney; Mice; Mice, Inbred Strains; Phorbols; Pregnancy; Tetradecanoylphorbol Acetate | 1985 |